| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4443952
Max Phase: Preclinical
Molecular Formula: C28H20ClFN4O4
Molecular Weight: 530.94
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4Cl)c(F)c3)cc3ccccc32)cc1
Standard InChI: InChI=1S/C28H20ClFN4O4/c1-37-19-9-7-18(8-10-19)34-22-5-3-2-4-16(22)14-20(28(34)36)27(35)33-17-6-11-23(21(30)15-17)38-24-12-13-32-26(31)25(24)29/h2-15H,1H3,(H2,31,32)(H,33,35)
Standard InChI Key: QWXXLFCEPWANSO-UHFFFAOYSA-N
Associated Targets(Human)
EBC-1 148 Activities
Hepatocyte growth factor receptor 10718 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 530.94 | Molecular Weight (Monoisotopic): 530.1157 | AlogP: 5.81 | #Rotatable Bonds: 6 |
| Polar Surface Area: 108.47 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 13.13 | CX Basic pKa: 5.97 | CX LogP: 4.78 | CX LogD: 4.76 |
| Aromatic Rings: 5 | Heavy Atoms: 38 | QED Weighted: 0.29 | Np Likeness Score: -1.33 |
References
| 1. Cui H, Peng X, Liu J, Ma C, Ji Y, Zhang W, Geng M, Li Y.. (2016) Design, synthesis and biological evaluation of c-Met kinase inhibitors bearing 2-oxo-1,2-dihydroquinoline scaffold., 26 (18): [PMID:27524312] [10.1016/j.bmcl.2016.07.077] |
Source
Source(1):